About
miRagen Therapeutics is a biotechnology company developing microRNA-targeted therapeutics, focusing on treatments for cardiovascular and fibrotic diseases. The company advances oligonucleotide-based programs designed to modulate microRNA activity to address underlying disease biology.
Explore miRagen Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.